NCT00136045View on ClinicalTrials.gov

Three Different Transdermal Doses of Rotigotine in Subjects With Idiopathic Restless Leg Syndrome

PHASE3CompletedINTERVENTIONAL
Enrollment

549

Participants

Timeline

Start Date

May 31, 2005

Primary Completion Date

August 31, 2006

Study Completion Date

August 31, 2006

Conditions
Restless Legs Syndrome
Interventions
DRUG

Rotigotine

Trial Locations (1)

Unknown

Schwarz, Monheim

Sponsors

Lead Sponsor

UCB Pharma
All Listed Sponsors
lead

UCB Pharma

INDUSTRY